- Global Private Group Company News Section

Global Private Group Press Release -

  • Oxyrane raises USD49.5 Million in Series D financing
  • Global Private Group has invested in Biopharmaceutical Company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than forty rare inherited diseases.
  • Series D financing round for the company raised USD 49.5M, Global Private Group was the sole arranger.

    The current fund will enable B ...
  • May 22, 2017